Feb 9 (Reuters)-
Rohto Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2015 Dec 31, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 120.32 107.46 167.50
(+12.0 pct) (+4.2 pct) (+10.4 pct)
Operating 11.86 9.00 15.10
(+31.7 pct) (-31.5 pct) (+14.7 pct)
Recurring 12.22 9.64 15.10
(+26.7 pct) (-28.2 pct) (+7.1 pct)
Net 7.81 5.85 9.50
(+33.5 pct) (-28.6 pct) (+10.1 pct)
EPS 68.69 yen 51.54 yen 83.57 yen
EPS Diluted 68.40 yen 51.32 yen
Ann Div 19.00 yen 20.00 yen
-Q2 div 10.00 yen 9.00 yen
-Q4 div 10.00 yen 10.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T
((Tokyo Headline News Desk +813 6441 1812))